| (BRL) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 6.96B | — |
| Operating expense | — | — |
| Net income | 2.02B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, GILD34.SA returned +26.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +11.9% |
| 1 year | +26.6% |
| 5 years | +137.4% |
| 10 years | +317.0% |
| All-time high | R$63.58 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what R$1,000 in GILD34.SA would be worth today ›Yes. Gilead Sciences, Inc. paid 4 dividends over the past 12 months. The most recent was R$0.25 per share on Jun 12, 2026. The dividend yield is 1.55%.
Gilead Sciences, Inc. is part of the Healthcare sector.
Gilead Sciences, Inc. has a market cap of 946.04B BRL, based on the latest quote.
